This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
ASCO 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population - Abstract
July 30, 2013
Pathologic examination of radical prostatectomies in men with very-low-risk disease at biopsy reveals distinct zonal distribution of cancer in African American men - Abstract
July 30, 2013
PSA screening for prostate cancer: Why so much controversy? - Abstract
July 30, 2013
GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update - Abstract
July 30, 2013
Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: A standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics - Abstract
July 30, 2013
A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study - Abstract
July 30, 2013
Major changes urged for cancer screening and treatment
July 30, 2013
Radium-223 chloride (Alpharadin) in patients with bone metastases and castration-resistant prostate cancer (CRPC): A new treatment paradigm - Video lecture by A. Oliver Sartor, MD
July 29, 2013
Defining a new testosterone threshold for medical castration: Results from a prospective cohort series - Abstract
July 29, 2013
Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy - Abstract
July 29, 2013
The modified Glasgow prognostic score in prostate cancer: Results from a retrospective clinical series of 744 patients - Abstract
July 29, 2013
Abdominal wall haemorrhage after robotic-assisted radical prostatectomy: Is it a complication of robotic surgery? - Abstract
July 29, 2013
Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen
July 29, 2013
Repetitively dosed docetaxel and (153)samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer - Abstract
July 29, 2013
FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems
July 29, 2013
Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer - Abstract
July 29, 2013
Hypofractionation for clinically localized prostate cancer - Abstract
July 29, 2013
Management of prostate cancer in elderly men - Abstract
July 29, 2013
Takeda announces unblinding of phase 3 study of orteronel in patients with metastatic, castration-resistant prostate cancer that progressed post-chemotherapy based on interim analysis
July 27, 2013
Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients - Abstract
July 27, 2013
Page 1127 of 1430
Start
Prev
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free